In a genetic preclinical study, embryonic GIPR knockout mice fed a high-fat diet were protected from obesity, supporting the role of GIPR antagonism as a method to promote weight loss and prevent weight gain (67)
Studies examining glutathione supplementation have used widely varying doses, typically ranging from 250 mg to 1,000 mg daily for reduced glutathione, though optimal dosing remains undetermined
Published data suggests ipamorelin may increase IGF-1 levels by 15-30% in responder populations, while sermorelin studies report variable outcomes ranging from modest to moderate GH elevation depending on dosing, frequency, and baseline age
Before diving into the current status of human studies, it's important to summarize key findings from animal models: These studies suggest a broad healing profile, but animal results don't always translate directly to humans